Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review

Gynecologic Oncology
R FruscioAnna Locatelli

Abstract

Treatment of locally invasive cervical cancer diagnosed during pregnancy in women who desire to retain their pregnancy is a major challenge to physicians. Neoadjuvant chemotherapy followed by radical hysterectomy has been reported to be an attractive option to delay delivery until fetal viability has been reached. Between 1994 and 2009 9 patients were treated at San Gerardo Hospital (Monza, Italy) for cervical cancer during pregnancy. FIGO stage was IB1 in four patients and IB2 in five. Tumor diameter ranged between 20 and 70 mm. After neoadjuvant platinum-based chemotherapy partial response was achieved in 5 patients, while 4 had a stable disease. One patient received a second-line chemotherapy during pregnancy due to progressive disease, achieving a partial response. Median duration of therapy delay until cesarean section was 16 weeks. Between 30 and 36 weeks of gestation all patients underwent cesarean section. Piver II radical hysterectomy with pelvic lymphadenectomy was performed. Two children had mild perinatal morbidities and were discharged in good conditions after 14 and 40 days. Three patients received adjuvant therapy for pathological risk factors. Four patients relapsed (44%) and two of them (23%) died because of tu...Continue Reading

References

Sep 1, 1996·British Journal of Obstetrics and Gynaecology·P L GiacaloneB Hedon
Aug 28, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W van VlietH Boonstra
Feb 13, 2001·Gynecologic Oncology·H R MaranaS Bighetti
Jun 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K OstromA L Kaplan
Mar 30, 2004·Gynecologic Oncology·Akila N ViswanathanPatricia J Eifel
Jan 26, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N GermannA Gerbaulet
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·George Pentheroudakis, Nicholas Pavlidis
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S CaluwaertsF Amant
Dec 13, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Yves BenhaimPhilippe Morice
Feb 13, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y BenhaimP Morice
May 31, 2007·Nature Clinical Practice. Oncology·Amer KaramChristine H Holschneider
Oct 2, 2007·American Journal of Obstetrics and Gynecology·Innocenza PalaiaPierluigi Benedetti Panici
May 9, 2008·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Rosanna G AbellarMonique E De Paepe
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth C SmythDesmond N Carney
Jul 20, 2011·Cancer Chemotherapy and Pharmacology·Olivier MirAxel Le Cesne

❮ Previous
Next ❯

Citations

Jan 21, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M J HalaskaL Rob
Oct 22, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Rehana DawoodSean Kehoe
Jul 3, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F A PeccatoriUNKNOWN ESMO Guidelines Working Group
Nov 21, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·M La Russa, A R Jeyarajah
Mar 4, 2015·American Journal of Obstetrics and Gynecology·Christhardt KöhlerSimone Marnitz
Nov 7, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Catherine M Albright, Katharine D Wenstrom
Dec 29, 2013·Gynecologic Oncology Case Reports·Christine Rojas, John W Moroney
Feb 25, 2014·Irish Journal of Medical Science·Y LiuJ Zhang
Nov 6, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Arunachalam Ilancheran
Nov 3, 2016·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A Surbone, C Achtari
Mar 18, 2017·Obstetrical & Gynecological Survey·Christina N Cordeiro, Mary L Gemignani
Mar 3, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kosuke YoshiharaTakayuki Enomoto
Oct 6, 2018·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Aline Figueredo de OliveiraRosekeila Simões Nomelini
Jan 16, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giuseppe Filiberto VercellinoVito Chiantera
Aug 31, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Caterina RicciRosa De Vincenzo
Jan 25, 2013·Obstetrics and Gynecology·Flora ZagouriRupert Bartsch
Oct 16, 2018·Minerva ginecologica·Stella CapriglioneSalvatore Lopez
Feb 23, 2019·Journal of Cellular Physiology·Anna Myriam PerronePierandrea De Iaco
Oct 4, 2017·BMC Pregnancy and Childbirth·Kathleen MelanClarisse Joachim
Mar 28, 2018·Cancer Biology & Therapy·Yuanyuan ChenFengxia Xue
Aug 16, 2019·Rare Tumors·Satoshi EtoHisashi Narahara
Nov 16, 2016·ESMO Open·Flora ZagouriMeletios-Athanassios Dimopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.